Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China · Delayed Price · Currency is CNY 12.26
-0.11 (-0.89%)
Feb 4, 2026, 11:29 AM CST
Jiangsu Yahong Meditech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 266.92 | 189.46 | 11.52 | 0.03 | 0 | - |
Other Revenue | 12.1 | 12.1 | 2.23 | - | - | - |
| 279.02 | 201.56 | 13.75 | 0.03 | 0 | - | |
Revenue Growth (YoY) | 86.37% | 1365.55% | 52604.89% | 470.51% | - | - |
Cost of Revenue | 76.37 | 50.32 | 2.93 | 1.83 | 1.19 | 0.2 |
Gross Profit | 202.64 | 151.25 | 10.83 | -1.81 | -1.19 | -0.2 |
Selling, General & Admin | 333.4 | 262.75 | 117.55 | 88.29 | 63.86 | 78.45 |
Research & Development | 262.72 | 311.92 | 364.59 | 243.89 | 190.74 | 172.03 |
Other Operating Expenses | -0.44 | 0.26 | -0.31 | 0.27 | 0.03 | 0.18 |
Operating Expenses | 599.93 | 577.62 | 482.29 | 332.46 | 254.64 | 250.66 |
Operating Income | -397.29 | -426.38 | -471.47 | -334.27 | -255.82 | -250.87 |
Interest Expense | -11.16 | -6.75 | -2.97 | -0.77 | -0.48 | -0.05 |
Interest & Investment Income | 25.9 | 38.65 | 48.02 | 26.64 | 14.44 | 2.95 |
Currency Exchange Gain (Loss) | -0.64 | -0.64 | -0.79 | 9.84 | -2.03 | -1.97 |
Other Non Operating Income (Expenses) | -2.38 | -2.09 | -0.76 | -0.16 | -0.36 | -0.55 |
EBT Excluding Unusual Items | -385.57 | -397.21 | -427.96 | -298.71 | -244.25 | -250.48 |
Gain (Loss) on Sale of Investments | 7.11 | 9.72 | 19.58 | 47.53 | 4.1 | 1.13 |
Gain (Loss) on Sale of Assets | 0 | 0.05 | - | - | -0.02 | - |
Asset Writedown | 0.94 | - | -0.03 | -0.01 | - | - |
Legal Settlements | -1.99 | -1.99 | - | - | - | - |
Other Unusual Items | 2.63 | 2.63 | 6.9 | 5.93 | 5.42 | 2.09 |
Pretax Income | -376.88 | -386.8 | -401.5 | -245.27 | -234.75 | -247.27 |
Income Tax Expense | -1.17 | -0.8 | -0.67 | 1.28 | 0.19 | - |
Earnings From Continuing Operations | -375.71 | -386 | -400.83 | -246.55 | -234.95 | -247.27 |
Minority Interest in Earnings | 13.54 | 1.94 | 0.4 | - | - | - |
Net Income | -362.17 | -384.06 | -400.43 | -246.55 | -234.95 | -247.27 |
Net Income to Common | -362.17 | -384.06 | -400.43 | -246.55 | -234.95 | -247.27 |
Shares Outstanding (Basic) | 566 | 565 | 572 | 573 | 461 | 458 |
Shares Outstanding (Diluted) | 566 | 591 | 598 | 573 | 461 | 458 |
Shares Change (YoY) | -0.27% | -1.14% | 4.24% | 24.46% | 0.61% | - |
EPS (Basic) | -0.64 | -0.68 | -0.70 | -0.43 | -0.51 | -0.54 |
EPS (Diluted) | -0.64 | -0.68 | -0.70 | -0.43 | -0.51 | -0.54 |
Free Cash Flow | -416.34 | -430.74 | -499.82 | -268.57 | -213.92 | -140.25 |
Free Cash Flow Per Share | -0.74 | -0.73 | -0.84 | -0.47 | -0.46 | -0.31 |
Gross Margin | 72.63% | 75.04% | 78.72% | - | - | - |
Operating Margin | -142.39% | -211.54% | -3428.02% | -1280959.60% | -5592976.39% | - |
Profit Margin | -129.80% | -190.54% | -2911.54% | -944816.18% | -5136625.82% | - |
Free Cash Flow Margin | -149.22% | -213.70% | -3634.18% | -1029206.22% | -4676788.98% | - |
EBITDA | -377.07 | -411.38 | -463.44 | -330.15 | -253.25 | -249.5 |
EBITDA Margin | -135.14% | -204.10% | - | - | - | - |
D&A For EBITDA | 20.22 | 14.99 | 8.03 | 4.11 | 2.57 | 1.36 |
EBIT | -397.29 | -426.38 | -471.47 | -334.27 | -255.82 | -250.87 |
EBIT Margin | -142.39% | -211.53% | - | - | - | - |
Revenue as Reported | 279.02 | 201.56 | 13.75 | 0.03 | 0 | - |
Advertising Expenses | - | 71.93 | 3.93 | 2.71 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.